Browse Menu >>

Browse Subjects >>

Biomedical & Life Sciences

Business & Economics

Chemistry & Materials Science

Computer Science & Communications

Earth & Environmental Sciences

Engineering

Medicine & Healthcare

Physics & Mathematics

Social Sciences & Humanities

Why Us? >>

  • - Open Access
  • - Peer-reviewed
  • - Rapid publication
  • - Lifetime hosting
  • - Free indexing service
  • - Free promotion service
  • - More citations
  • - Search engine friendly

Free SCIRP Newsletters>>

Add your e-mail address to receive free newsletters from SCIRP.

 

Contact Us >>

WhatsApp  +86 18163351462(WhatsApp)
   
Paper Publishing WeChat
Book Publishing WeChat
(or Email:book@scirp.org)

Article citations

More>>

Tournigand, C., et al. (2012) Adjuvant Therapy with Fluorouracil and Oxaliplatin in Stage II and Elderly Patients (between Ages 70 and 75 Years) with Colon Cancer: Subgroup Analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer Trial. Journal of Clinical Oncology, 30, 3353-3360.
https://doi.org/10.1200/JCO.2012.42.5645

has been cited by the following article:

  • TITLE: A Sustained Complete Response in an Elderly Patient with Metastatic Colorectal Adenocarcinoma—A Clinical Case

    AUTHORS: Maria Leitão, Isabel Vilas-Boas, Manuela Machado

    KEYWORDS: Elderly, Chemotherapy, Cancer, Colorectal

    JOURNAL NAME: Journal of Cancer Therapy, Vol.11 No.6, May 29, 2020

    ABSTRACT: Background: The increasing life expectancy of people worldwide will signify that oncologists everywhere will be faced with many difficult decisions regarding treatment options in the elderly population with cancer. These patients carry specific challenges that should be discussed. Aim: To report the clinical case of an elderly patient with a metastatic colorectal cancer with a sustained complete response and reflect on the particularities on this special population. Clinical case: In 2009, an 80-year-old man presents with colorectal cancer, undergoes surgery and intraoperatively a peritoneal implant is resected. He is deemed fit for chemotherapy and is treated with 8 cycles of capecitabine. After a 10-year follow-up, he remains with no evidence of disease. Conclusion: Chronological age is insufficient to establish a treatment plan; oncologists must evaluate the patient multidimensionally and develop personalized options for the therapy and follow-up of older individuals.